WO2009082818A8 - Novel c-21-keto lupane derivatives preparation and use thereof - Google Patents
Novel c-21-keto lupane derivatives preparation and use thereof Download PDFInfo
- Publication number
- WO2009082818A8 WO2009082818A8 PCT/CA2008/002290 CA2008002290W WO2009082818A8 WO 2009082818 A8 WO2009082818 A8 WO 2009082818A8 CA 2008002290 W CA2008002290 W CA 2008002290W WO 2009082818 A8 WO2009082818 A8 WO 2009082818A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- keto
- novel
- derivatives preparation
- formula
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008801275023A CN101977924A (en) | 2008-01-03 | 2008-12-23 | Novel c-21-keto lupane derivatives preparation and use thereof |
MX2010007374A MX2010007374A (en) | 2008-01-03 | 2008-12-23 | Novel c-21-keto lupane derivatives preparation and use thereof. |
AU2008342536A AU2008342536A1 (en) | 2008-01-03 | 2008-12-23 | Novel C-21-keto lupane derivatives preparation and use thereof |
JP2010540996A JP2011508747A (en) | 2008-01-03 | 2008-12-23 | Novel C-21 kettle bread derivatives, their preparation and use |
EP08867782A EP2240504A1 (en) | 2008-01-03 | 2008-12-23 | Novel c-21-keto lupane derivatives preparation and use thereof |
CA2711420A CA2711420A1 (en) | 2008-01-03 | 2008-12-23 | Novel c-21-keto lupane derivatives preparation and use thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1876608P | 2008-01-03 | 2008-01-03 | |
US61/018,766 | 2008-01-03 | ||
US3968008P | 2008-03-26 | 2008-03-26 | |
US61/039,680 | 2008-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009082818A1 WO2009082818A1 (en) | 2009-07-09 |
WO2009082818A8 true WO2009082818A8 (en) | 2009-09-03 |
Family
ID=40823728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2008/002290 WO2009082818A1 (en) | 2008-01-03 | 2008-12-23 | Novel c-21-keto lupane derivatives preparation and use thereof |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2240504A1 (en) |
JP (1) | JP2011508747A (en) |
CN (1) | CN101977924A (en) |
AU (1) | AU2008342536A1 (en) |
CA (1) | CA2711420A1 (en) |
MX (1) | MX2010007374A (en) |
WO (1) | WO2009082818A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8993542B2 (en) * | 2008-01-25 | 2015-03-31 | Chimerix Inc. | Methods of treating viral infections |
US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
EA202190473A3 (en) | 2010-01-27 | 2021-12-31 | Вайв Хелткер Компани | ANTIVIRAL THERAPY |
WO2011100308A1 (en) * | 2010-02-11 | 2011-08-18 | Glaxosmithkline Llc | Derivatives of betulin |
EP2534150B1 (en) | 2010-02-12 | 2017-04-05 | Chimerix, Inc. | Methods of treating viral infection |
AU2011248620B2 (en) | 2010-04-26 | 2015-11-26 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
WO2013020245A1 (en) * | 2011-08-08 | 2013-02-14 | Glaxosmithkline Llc | Carbonyl derivatives of betulin |
JO3387B1 (en) | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | Derivatives of betulin |
CN104844679B (en) * | 2011-12-16 | 2017-03-01 | 葛兰素史克有限责任公司 | The derivant of betulin |
CN103242413B (en) * | 2012-02-08 | 2015-08-26 | 江西青峰药业有限公司 | Lupane triterpene system's derivative and pharmaceutical use thereof |
CN104902905A (en) | 2012-12-14 | 2015-09-09 | 葛兰素史克有限责任公司 | Pharmaceutical compositions |
US9637516B2 (en) | 2012-12-31 | 2017-05-02 | Hetero Research Foundation | Betulinic acid proline derivatives as HIV inhibitors |
US20170129916A1 (en) | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
AU2015323321A1 (en) | 2014-09-26 | 2017-04-13 | Glaxosmithkline Intellectual Property (No.2) Limited | Long acting pharmaceutical compositions |
MA40886B1 (en) | 2015-02-09 | 2020-03-31 | Hetero Research Foundation | Novel c-3 triterpenone with c-28 reverse amide derivatives as hiv inhibitors |
US10370405B2 (en) * | 2015-03-16 | 2019-08-06 | Hetero Labs Limited | C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors |
WO2017115329A1 (en) * | 2015-12-30 | 2017-07-06 | Hetero Research Foundation | C-3 novel triterpenone derivatives as hiv inhibitors |
US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
-
2008
- 2008-12-23 MX MX2010007374A patent/MX2010007374A/en not_active Application Discontinuation
- 2008-12-23 AU AU2008342536A patent/AU2008342536A1/en not_active Abandoned
- 2008-12-23 CN CN2008801275023A patent/CN101977924A/en active Pending
- 2008-12-23 WO PCT/CA2008/002290 patent/WO2009082818A1/en active Application Filing
- 2008-12-23 EP EP08867782A patent/EP2240504A1/en not_active Withdrawn
- 2008-12-23 CA CA2711420A patent/CA2711420A1/en not_active Abandoned
- 2008-12-23 JP JP2010540996A patent/JP2011508747A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2008342536A1 (en) | 2009-07-09 |
EP2240504A1 (en) | 2010-10-20 |
JP2011508747A (en) | 2011-03-17 |
CA2711420A1 (en) | 2009-07-09 |
WO2009082818A1 (en) | 2009-07-09 |
MX2010007374A (en) | 2010-10-05 |
CN101977924A (en) | 2011-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009082819A8 (en) | Novel lupane derivatives | |
WO2009082818A8 (en) | Novel c-21-keto lupane derivatives preparation and use thereof | |
WO2012142093A3 (en) | 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
PH12017501429A1 (en) | Derivatives of betulin | |
WO2017123884A8 (en) | Heterocyclic compounds as rsv inhibitors | |
WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
MX2022013596A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use. | |
WO2020257549A3 (en) | Compounds for treatment of pd-l1 diseases | |
EP4316591A3 (en) | Oxysterols and methods of use thereof | |
WO2012122340A8 (en) | Soluble guanylate cyclase activators | |
WO2008012635A3 (en) | Amine derivatives useful as anticancer agents | |
WO2012125926A3 (en) | Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases | |
WO2009063202A3 (en) | Use of crth2 antagonist compounds | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
WO2011044501A3 (en) | Antibacterial aminoglycoside analogs | |
WO2010132757A3 (en) | Antibacterial aminoglycoside analogs | |
EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
WO2011005811A8 (en) | Combination therapy for the treatment of diabetes | |
WO2010030704A3 (en) | Antibacterial aminoglycoside analogs | |
CA2862755A1 (en) | Antiviral compounds with a dibenzooxaheterocycle moiety | |
NZ600912A (en) | Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection | |
WO2014172188A3 (en) | 4-pyridone derivative compounds and uses thereof as hiv integrase inhibitors | |
WO2011025982A3 (en) | Tetracycline compounds | |
WO2013057251A3 (en) | Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease | |
IL276194B2 (en) | Compounds or pharmaceutical compositions comprising them for use in the treatment of paininhibiting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880127502.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08867782 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010540996 Country of ref document: JP Ref document number: 2711420 Country of ref document: CA Ref document number: MX/A/2010/007374 Country of ref document: MX |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2577/KOLNP/2010 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008342536 Country of ref document: AU Ref document number: 586812 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008867782 Country of ref document: EP |
|
ENP | Entry into the national phase in: |
Ref document number: 2008342536 Country of ref document: AU Date of ref document: 20081223 Kind code of ref document: A |